Evidence map›Paper›PMID 36198800›Full record

ArticleNature2022

SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry.

John Kee, Samuel Thudium, David M Renner, Karl Glastad, Katherine Palozola, Zhen Zhang, Yize Li, Yemin Lan, Joseph Cesare, Andrey Poleshko and 15 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 146 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Targeting G9a-miScience · 2025
    Article
  17. The Recurring Loss of ORF8 Secretion in Dominant SARS-CoV-2 Variants.International journal of molecular sciences · 2025
    Article
  18. Article
  19. Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 1 country.

John KeeDepartment of Genetics at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Samuel Thudium *Department of Genetics at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-6670-3970
David M Renner *Department of Microbiology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0548-3876
Karl Glastad *Epigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Katherine PalozolaDepartment of Genetics at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Zhen ZhangEpigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Yize LiDepartment of Microbiology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-1721-741X
Yemin LanEpigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Joseph CesareEpigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-5569-1422
Andrey PoleshkoDepartment of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-6656-2941
Anna A KiselevaDepartment of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-8720-5062
Rachel TruittDepartment of Medicine at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Fabian L Cardenas-DiazDepartment of Medicine at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Xianwen ZhangDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Xuping XieDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.ORCID http://orcid.org/0000-0003-0918-016X
Darrell N KottonCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9604-8476
Konstantinos D AlysandratosCenter for Regenerative Medicine, Boston University and Boston Medical Center, Boston, MA, USA.
Jonathan A EpsteinDepartment of Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Pei-Yong ShiDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.ORCID http://orcid.org/0000-0001-5553-1616
Wenli YangDepartment of Medicine at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-1873-2336
Edward MorriseyDepartment of Medicine at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Benjamin A GarciaEpigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Shelley L BergerEpigenetics Institute at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-5398-4400
Susan R WeissDepartment of Microbiology at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Erica KorbDepartment of Genetics at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. ekorb@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-7064-8123
University of Pennsylvania · USThe University of Texas Medical Branch at Galveston · USBoston University · USCalifornia Institute for Regenerative Medicine · US

Funding

Virology CoreU19AI171413 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SARKO, CHRISTOPHER · 2022 to 2023
$75.0M
Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI MUIR, TOM · 2015 to 2024
$17.6M
West African Center for Emerging Infectious DiseasesU01AI151801 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Robert W Cross, Scott C Weaver · 2020 to 2026
$10.1M
Cardiac lineage determination and nuclear architectureR35HL140018 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI EPSTEIN, JONATHAN A. · 2018 to 2024
$6.8M
Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteinsR01AI140442 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Susan R Weiss · 2018 to 2026
$5.1M
Training in Emerging Infectious DiseasesT32AI055400 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA, HENSLEY, SCOTT ERIC · 2003 to 2022
$4.4M
A National iPS Cell Network with Deep Phenotyping for Translational ResearchU01TR001810 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILAD, YOAV, KOTTON, DARRELL N. · 2016 to 2020
$4.4M
Quantitative mass spectrometry for comprehending epigenetic mechanisms in a new underlying neurological developmental disorderR01HD106051 · NICHD · WASHINGTON UNIVERSITY · PI Benjamin A Garcia · 2022 to 2026
$2.6M
The epigenetic encoding of learning and memoryDP2MH129985 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KORB, ERICA MEGAN · 2021 to 2024
$2.4M
The Histone Code of Neuronal Function and DysfunctionR00MH111836 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KORB, ERICA MEGAN · 2019 to 2021
$745k
NCATS NIH HHS U01 TR001810NCI NIH HHS P01 CA196539NHLBI NIH HHS R35 HL140018NIAID NIH HHS HHSN272201600013CNIAID NIH HHS R01 AI118891NIAID NIH HHS R01 AI140442NIAID NIH HHS T32 AI055400NIAID NIH HHS U01 AI151801NIAID NIH HHS U19 AI171413NICHD NIH HHS R01 HD106051NIMH NIH HHS DP2 MH129985NIMH NIH HHS R00 MH111836
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged at the end of 2019 and caused the devastating global pandemic of coronavirus disease 2019 (COVID-19), in part because of its ability to effectively suppress host cell responses

Indexed as

COVID-19Epigenesis, GeneticHistonesHost Microbial InteractionsMolecular MimicrySARS-CoV-2Viral ProteinsChromatinChromatin Assembly and DisassemblyEpigenomeHumansChromatinHistonesORF8 protein, SARS-CoV-2Viral Proteins

Identifiers

PMID36198800
PMCPMC9533993
OpenAlexW4302010978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.